Partner Headlines - XLV

  1. Weighing the Week Ahead: Will Q4 Earnings Confirm Recent Economic ...

    TalkMarkets
  2. Danger Lurks As Extremes Become The Norm

    TalkMarkets
  3. VIX-Crushing, Panic-Buying Bounce Saves Stocks From Worse Day ...

    TalkMarkets
  4. Energy-Sector Momentum Continues To Lead US Stocks Higher

    TalkMarkets
  5. Canada ETF Grabs the Global Leadership

    TalkMarkets
  6. Meet The Press

    TalkMarkets
  7. Dollar Dumped, Stocks Trump'd, Gold Jumped

    TalkMarkets
  8. Bullion, Biotechs, & Banks Bid As Bonds & Black Gold Skid

    TalkMarkets
  9. The Hidden Risks and Costs of ETFs

    ETFdb
  10. Crude Crushed, Dollar Dumps As Bonds & Bullion Bounce

    TalkMarkets
  11. Sell on the Pop Prospects: January 9 Edition

    ETFdb
  12. The Problem With Forecasts

    TalkMarkets
  13. Shining A Spotlight On Ailing Health Care ETFs

    TalkMarkets
  14. Biotech Blahs: Out Of Favor But Great For Stock Pickers

    TalkMarkets
  15. 2017 Stock Market Forecast

    TalkMarkets
  16. Bonds & Bullion Bounce But Banks Bruised As Dollar Dumps

    TalkMarkets
  17. Rebalance Rout: Stocks Slump Most Since October As Bonds, Bullion ...

    TalkMarkets
  18. Market Outlook 2017: Where to Invest – and What to Avoid – in ...

    TalkMarkets
  19. Potential Risks to the U.S. Economy in 2017

    TalkMarkets
  20. Dow 20k Disappoints For 10th Day Despite Market Optimism Surging ...

    TalkMarkets
  21. Sell on the Pop Prospects: December 26 Edition

    ETFdb
  22. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets
  23. Sell on the Pop Prospects: December 19 Edition

    ETFdb
  24. Fed’s Fantasy Vs. Reality

    TalkMarkets
  25. High Beta Continues As Top ETF Factor

    TalkMarkets
  26. VIX Up, Stocks Up, Bonds Up... Fed Up!

    TalkMarkets
  27. Biotechs Mixed Hurt By Alexion And Ophthotech

    TalkMarkets
  28. Sell on the Pop Prospects: December 12 Edition

    ETFdb
  29. Dow 20,000 12-9-16

    TalkMarkets
  30. Another Day, Another Melt-Up In Stocks As Gold Hits 10-Month ...

    TalkMarkets
  31. Small-Cap ETFs Poised For Big Weekly Gains And Biotechs Bounce ...

    Investors Business Daily
  32. Bullish Momentum Revives The Energy Sector’s Price Trend

    TalkMarkets
  33. Biotechs Unhinged By Tough Pricing Talk

    TalkMarkets
  34. Stock ETFs Mixed As Biotechs Take Ill On A Single Donald Trump ...

    Investors Business Daily
  35. As Rome Burns... Investors Dump Gold, Send US Equity Markets ...

    TalkMarkets
  36. Reliable Contrarian Indicator Says Stocks Could Rise 25%

    TalkMarkets
  37. Pay Attention To Sector Rotation

    TalkMarkets
  38. Trumponomics – The New Hope

    TalkMarkets
  39. Rare Monthly Signals Paint A Clear Picture

    TalkMarkets
  40. Market Forecast For 2017: SPX At 2400 By End Of Year

    TalkMarkets
  41. November To Remember - Unprecedented Month In Markets Ends Weak

    TalkMarkets
  42. Big-Dividend Healthcare REITs, Ranking the Best and Worst

    TalkMarkets
  43. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech? ...

    TalkMarkets
  44. Don’t Be The Turkey

    TalkMarkets
  45. Why The Trump Market Crash Reversed, And Then Went Higher

    TalkMarkets
  46. ETF Asset Flow In Election Week

    TalkMarkets
  47. Three Quick and Easy Profit Plays to Make Right Now

    TalkMarkets
  48. “Trexit” Bounce – Opportunities & Warnings

    TalkMarkets
  49. 5 Stocks To Watch On Icahn & Paulson's Gain From Trump Win

    TalkMarkets
  50. T2108 Update – Trump Trades: Divergences and Rotations

    TalkMarkets
  51. The Great Trump Rotation

    TalkMarkets
  52. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets
  53. Healthcare Likely to Benefit from Trump Victory

    TalkMarkets
  54. 10 ETFs To Watch Today And After The Election

    TalkMarkets
  55. Healthcare ETFs In The Spotlight As Election Approaches

    TalkMarkets
  56. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets
  57. Market Breaks Support As Sell Signals Trigger

    TalkMarkets
  58. Markets 'Turmoil' After Comey Crashes Clinton Party

    TalkMarkets
  59. "Is The Neighborhood Burning Down?": Healthcare Stocks Tumble ...

    TalkMarkets
  60. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  61. This Or That 10-21-16

    TalkMarkets
  62. This Or That 10-22-16

    TalkMarkets
  63. Alert: Biotechnology And Health Sector Testing Long Time Support

    TalkMarkets
  64. Buy UnitedHealth ETFs On Upbeat Q3 Earnings

    TalkMarkets
  65. Stocks Pop, but Fizzle during Late Day Fade

    TalkMarkets
  66. Fed Minutes Show Conflicted Central Bank

    TalkMarkets
  67. Biotechnology Bear Market: Trends To Watch For A 2016 Q4 Rally

    TalkMarkets
  68. Illumina Misses Revenue Forecast Causing Collateral Damage To ...

    TalkMarkets
  69. A Change In Sector Leadership Puts Tech In The Lead

    TalkMarkets
  70. Why You Can Beat The Market More Easily Trading Sector ETF

    TalkMarkets
  71. How Will Energy ETFs Be Affected If Trump Wins

    ETFdb
  72. If Hillary Clinton Wins

    ETFdb
  73. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets
  74. How Will Healthcare Stocks Be Affected If Hillary Clinton Wins?

    Dividend.com
  75. Biotech ETFs Rally As Oil Bubbles Up 8%; Gold Hits 3-Month High

    IBD
  76. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD
  77. 4 ETF Strategists Weigh In On U.S., European Markets

    IBD
  78. Energy, TIPs And Biotechnology ETFs To Watch This Week

    Benzinga
  79. SPDR ETFs: Why Is State Street's Nick Good Excited About 2015?

    IBD
  80. Emerging Market Bond, Oil And Healthcare ETFs To Watch This Week

    Benzinga
  81. How To Plan An XLV Call Ratio Spread

    Benzinga
  82. Global X Launches Two New Rules-Based ETFs

    Benzinga
  83. Worried? Picks Of Mr. Cautious, 80% In Stocks

    YCharts
  84. Which Fund Has The Most To Gain From Biogen Idec?

    Benzinga
  85. ArrowShares Launches New Tactical ETF

    Benzinga
  86. What Do The Sectors Say About Technical Divergences?

    Benzinga
  87. Sigma-Aldrich Hits High On Sale To Germany's Merck

    IBD
  88. With Actively Managed Funds, Be Wary Of Expense Ratios

    Benzinga
  89. Build a "Whatever Happens" Portfolio - Now!

    GuruFocus
  90. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga
  91. Standout In Pharma Supply Chain’s Growth Story

    YCharts
  92. Sell-In-May: Seasonal Winners and Losers Listed

    YCharts
  93. Growth Story: Fund Managers Buy Healthcare

    YCharts
  94. Biotech ETFs Come Back Down To Earth

    Benzinga
  95. Are Earnings Important? These Days, Revenues Count for More!

    GuruFocus
  96. Why Mr. Cautious Is 82% Invested In Stocks

    YCharts
  97. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  98. Health Care ETFs After Obamacare (IHF, XLV, UNH, ESRX)

    Benzinga
  99. These Industry ETFs Will Keep Soaring

    Benzinga
  100. Thinking of Investing with a Hedge Fund?

    GuruFocus
Trading Center